It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2009.
2009 | Mumbai, Maharashtra, India | ActiveJinendra Qualipharm Private Limited, a active private limited company, was established on 15 October 2009 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U24100MH2009PTC196480. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.43 M.
It upholds a compliant status. Its leadership includes Ajit Jain (Director), Anju Jain (Director), Drishti Ajit Jain (Additional Director). Past directors included Ajit Jain, Anju Jain, Suresh Somchand Shah. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No. B-4001, 40Th Floor, B Wing, Lodha Evoq, Plot No.Block-C (C1 – Zone), Wadala Truc, K Terminal, Mumbai, Maharashtra, 400037.
U24100MH2009PTC196480
196480
15 October 2009
₹0.50 M
₹0.43 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Jinendra Qualipharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajit Jain | Director | 14 Jun 2022 | Current |
| Anju Jain | Director | 27 Jan 2015 | Current |
| Drishti Ajit Jain | Additional Director | 23 Dec 2024 | Current |
| Tina Aayush Jain | Additional Director | 23 Dec 2024 | Current |
| Aayush Jain | Director | 27 Jan 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 02 Feb 2010 | Past |
| Pramod Abcsdd | Director | 28 Jan 2015 | Past |
| Pramod Abcsdd | Director | 28 Jan 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jinendra Qualipharm Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.03% decrease. The company also saw a substantial fall in profitability, with a 33.61% decrease in profit. The company's net worth Soared by an impressive increase of 39.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Jinendra Qualipharm had a public holding of 76.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Jinendra Qualipharm, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Jinendra Qualipharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jinendra Qualipharm's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jinendra Qualipharm Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Jinendra Qualipharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Progress on Drishti Ajit Jain was appointed as a Additional Director was appointed as a Additional Director on 23 Dec 2024 & has been associated with this company since 11 months 5 days . was documented.
Progress on Tina Aayush Jain was appointed as a Additional Director was appointed as a Additional Director on 23 Dec 2024 & has been associated with this company since 11 months 5 days . was documented.
Ajit Jain was appointed as a Director was appointed as a Director on 14 Jun 2022 & has been associated with this company since 3 years 5 months . was recorded as a recent event.
Progress on Anju Jain was appointed as a Director was appointed as a Director on 27 Jan 2015 & has been associated with this company since 10 years 10 months . was documented.
The CIN of Jinendra Qualipharm Private Limited is U24100MH2009PTC196480.
Jinendra Qualipharm Private Limited is headquartered at Flat No. B-4001, 40Th Floor, B Wing, Lodha Evoq, Plot No.Block-C (C1 – Zone), Wadala Truc, K Terminal, Mumbai, Maharashtra, 400037.
Jinendra Qualipharm Private Limited was incorporated on 15 October 2009.
The current directors of Jinendra Qualipharm Private Limited are
The primary industry of Jinendra Qualipharm Private Limited is Professional, Scientific And Technical.
Jinendra Qualipharm Private Limited is unlisted.
The authorized capital of Jinendra Qualipharm Private Limited is ₹0.50 M, and the paid-up capital is ₹0.43 M.
The compliance status of Jinendra Qualipharm Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX